CTT Systems AB (CTT)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 131.00 |
|---|---|
| 52-week range | 112.40 – 210.22 |
| Return, 1 month / 3 months | −1.8% / +7.7% |
| Return, 1 year / 3 years | −35.1% / −34.8% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 46.4% |
| Worst drawdown (1 year) | -45.1% |
| Average daily value traded | 1.04M SEK |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CTT Systems develops and supplies humidification and dehumidification equipment for aircraft cabins. Its systems add moisture to cabin air on long-haul flights and remove excess moisture from areas such as cargo holds and crew rest compartments. Airlines and aircraft manufacturers are the main customers, and the equipment is fitted to aircraft from major planemakers. The company is based in Sweden and serves aviation customers around the world.
CTT Systems AB trades under the code CTT on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CTT Systems AB (CTT) trades on the Stockholm Exchange in Sweden. It last closed at SEK 131.00 on 19 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 458 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.1% and over the last three months it rose 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -37.0% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.7% | ||
| 6-month return | -4.7% | ||
| 12-month return, skipping the last month | -33.9% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.1% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.04M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | −1.8% |
| 3 months | +7.7% |
| 6 months | −4.7% |
| 1 year | −35.1% |
| 3 years | −34.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 134.20 / 135.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | SEK 2.4000 |
| 9 May 2025 | SEK 5.3500 |
| 7 May 2024 | SEK 5.3500 |
| 5 May 2023 | SEK 4.0500 |
| 5 May 2022 | SEK 0.7900 |
| 6 May 2021 | SEK 1.7400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.